236 related articles for article (PubMed ID: 33309764)
1. Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study.
Denas G; Gennaro N; Ferroni E; Fedeli U; Lorenzoni G; Gregori D; Iliceto S; Pengo V
Int J Cardiol; 2021 Apr; 329():266-269. PubMed ID: 33309764
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
[TBL] [Abstract][Full Text] [Related]
3. Death rates and causes in anticoagulated atrial fibrillation patients: a population-based study.
Denas G; Fedeli U; Gennaro N; Ferroni E; Corti MC; Pengo V
J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):415-419. PubMed ID: 32355064
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19.
Rivera-Caravaca JM; Núñez-Gil IJ; Vivas D; Viana-Llamas MC; Uribarri A; Becerra-Muñoz VM; Trabattoni D; Fernández Rozas I; Feltes G; López-Pais J; El-Battrawy I; Macaya C; Fernandez-Ortiz A; Estrada V; Marín F;
Eur J Clin Invest; 2021 Jan; 51(1):e13436. PubMed ID: 33080051
[TBL] [Abstract][Full Text] [Related]
5. Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?
Covino M; De Matteis G; Della Polla D; Burzo ML; Pascale MM; Santoro M; De Cristofaro R; Gasbarrini A; De Candia E; Franceschi F
Aging Clin Exp Res; 2021 Aug; 33(8):2335-2343. PubMed ID: 34216379
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study.
Admassie E; Chalmers L; Bereznicki LR
J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):329-336. PubMed ID: 29642709
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation Management and Outcomes in Patients With Covid-19 With Propensity Score Matching: A Multicenter Retrospective Cohort Study.
Kaur J; deLongpre J; Koehler T; Laclair H; Bowen M; Khine J; Khosrodad N; Jena N; Dixit P; Yadav S; Mogulla SM; Coakley R; Sule A; Krishnamoorthy G
Am J Ther; 2021 Nov; 29(1):e43-e49. PubMed ID: 34994348
[TBL] [Abstract][Full Text] [Related]
8. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW
Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study.
Chocron R; Galand V; Cellier J; Gendron N; Pommier T; Bory O; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Geneste L; Schmeltz A; Panagides V; Philippe A; Marsou W; Ben Abdallah I; Deney A; El Batti S; Attou S; Juvin P; Delmotte T; Messas E; Pezel T; Planquette B; Duceau B; Gaussem P; Sutter W; Sanchez O; Waldman V; Diehl JL; Mirault T; Bonnet G; Cohen A; Smadja DM;
J Am Heart Assoc; 2021 Apr; 10(8):e018624. PubMed ID: 33550816
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
Flaker G; Lopes RD; Hylek E; Wojdyla DM; Thomas L; Al-Khatib SM; Sullivan RM; Hohnloser SH; Garcia D; Hanna M; Amerena J; Harjola VP; Dorian P; Avezum A; Keltai M; Wallentin L; Granger CB;
J Am Coll Cardiol; 2014 Oct; 64(15):1541-50. PubMed ID: 25301455
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion.
Själander S; Svensson PJ; Friberg L
Int J Cardiol; 2016 Jul; 215():360-3. PubMed ID: 27128562
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
Denas G; Gennaro N; Ferroni E; Fedeli U; Saugo M; Zoppellaro G; Padayattil Jose S; Costa G; Corti MC; Andretta M; Pengo V
Int J Cardiol; 2017 Dec; 249():198-203. PubMed ID: 28935464
[TBL] [Abstract][Full Text] [Related]
13. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study.
Anguita Sánchez M; Bertomeu Martínez V; Ruiz Ortiz M; Cequier Fillat Á; Roldán Rabadán I; Muñiz García J; Badimón Maestro L; Esteve Pastor MA; Marín Ortuño F;
Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):14-20. PubMed ID: 31160265
[TBL] [Abstract][Full Text] [Related]
14. Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillation.
Arbel R; Sergienko R; Hammerman A; Dotan-Greenberg S; Batat E; Avnery O; Greenberg D; Ellis MH
Heart; 2019 Oct; 105(19):1487-1492. PubMed ID: 30971403
[TBL] [Abstract][Full Text] [Related]
15. The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review.
Wijaya I; Andhika R; Huang I
Clin Appl Thromb Hemost; 2020; 26():1076029620960797. PubMed ID: 33079569
[TBL] [Abstract][Full Text] [Related]
16. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
17. Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes.
Rivera-Caravaca JM; Buckley BJR; Harrison SL; Fazio-Eynullayeva E; Underhill P; Marín F; Lip GYH
Thromb Res; 2021 Sep; 205():1-7. PubMed ID: 34218058
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
[TBL] [Abstract][Full Text] [Related]
19. Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study.
Fauchier L; Clementy N; Bisson A; Stamboul K; Ivanes F; Angoulvant D; Babuty D; Lip GY
Clin Res Cardiol; 2017 Mar; 106(3):202-210. PubMed ID: 27695988
[TBL] [Abstract][Full Text] [Related]
20. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants.
Ashley J; McArthur E; Bota S; Harel Z; Battistella M; Molnar AO; Jun M; Badve SV; Garg AX; Manuel D; Tanuseputro P; Wells P; Mavrakanas T; Rhodes E; Sood MM
Am J Kidney Dis; 2020 Sep; 76(3):311-320. PubMed ID: 32333946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
